November 20, 2024
The UNC Special Pathogens Response Center (SPARC) at UNC Hospitals is a regional and national resource for safely caring for patients with a special pathogen. Get an inside look on how healthcare professionals prepare and train during an exercise at the UNC Medical Center.
July 22, 2024
Researchers in the lab of Jenny Ting, PhD, the William Kenan Distinguished Professor of Genetics and professor of microbiology and immunology, have made numerous findings about how cell death from SARS-CoV-2 infection may directly influence disease progression.
February 29, 2024
In this new Vital Signs series, we feature graduate student Elizabeth Minor in the Ehre lab. Inspired by an immunology and cancer immunotherapy class during her time at the University of Virginia, Minor now studies viral challenges like SARS-CoV-2 and cystic fibrosis at the prestigious Marsico Lung Institute/UNC Cystic Fibrosis Center.
October 31, 2023
An international research team, including Jonathan C. Schisler, PhD, in the UNC School of Medicine, has found how SARS-CoV-2 causes widespread “energy outages” throughout major organs, and how these effects contribute to debilitating long COVID symptoms.
August 1, 2023
UNC has been selected as a participating site in the RECOVER-VITAL trial. A team of clinicians and researchers from across UNC will contribute to this nationwide work by identifying, treating, and evaluating patients over a six-month study period.
July 11, 2023
Springer recently released "Chronic Illness Care, Principles and Practice," edited by UNC Family Medicine's Timothy P. Daaleman, DO, MPH, and Margaret R. Helton, MD. Faculty members in the Department of Family Medicine, faculty across the UNC-Chapel Hill campus, and other national and international experts wrote the textbook.
June 27, 2023
A new study by researchers in the UNC School of Medicine, including Meghan Rebuli, PhD, Ilona Jaspers, PhD, and Kevin T. Cao, has found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity.
June 9, 2023
John Buse, MD, PhD, co-authored a study showing that the common diabetes drug metformin substantially decreased the risk of developing long COVID after infection from SARS-CoV-2. The clinical trial was led by researchers at the University of Minnesota.
April 25, 2023
The outbreak of Covid-19 presented many dangers for children, and a new study suggests increased illicit substance ingestions were among them. Lead study author Brittany Raffa, MD, clinical instructor in the Department of Pediatrics at the UNC School of Medicine, talks with CNN Health about the overall stress and parental substance use that contributed to the increase.
February 28, 2023
David Wohl, MD, and Billy Fischer, MD, published an op-ed in the News & Observer, The Charlotte Observer, and McClatchy subsidiaries on their work trying to gain a better understanding of COVID-19 through a largely observation study of thousands of volunteers in North Carolina.
February 22, 2023
NIH-supported studies, including one from UNC School of Medicine’s Emily Pfaff, PhD, co-first author of the study, Coding long COVID: characterizing a new disease through an ICD-10 lens, show variations in long COVID symptoms and diagnostic experiences among different racial and ethnic groups.
December 1, 2022
This research in an infant model was led by researchers from the UNC School of Medicine, Weill Cornell Medicine and University of California, Davis. Kristina De Paris, PhD, professor in the UNC Department of Microbiology & Immunology co-led this project.